Know How to Manage Dyslipidemia in Patients Living With HIV
August 2019
Better antiretroviral therapy means more patients with HIV will face dyslipidemia and CV disease...instead of opportunistic infections.
HIV itself increases CV risk...possibly by triggering inflammatory mediators linked to atherosclerosis or platelet activation.
And early use of antiretrovirals is key...since uncontrolled HIV carries a higher risk of MI, stroke, heart failure, etc.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: PA includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote